SCHEMBL20375290

SCHEMBL20375290

O=C(OC1CCCCCCCC1)C1CC2C=CC1C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 7/20 0.39
KMT2A Q03164 2/20 0.38
RAB9A P51151 1/20 0.38
FABP7 O15540 1/20 0.37
FABP5 Q01469 1/20 0.37
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 3/20 0.36
APEX1 P27695 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
ESR2 Q92731 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.36
EPHX1 P07099 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11908671 1.00 LMNA (0.46) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL28630522 1.00 LMNA (0.46) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL947840 1.00 LMNA (0.46) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL3365931 0.98 LMNA (0.47) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL11908078 0.84 ALDH1A1 (0.48) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL11908819 0.84 ALDH1A1 (0.48) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL2135609 0.84 KDM4E (0.44) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL13888469 0.84 KDM4E (0.44) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL11909877 0.82 ALDH1A1 (0.49) LMNAKDM4EALDH1A1KMT2ARAB9A
SCHEMBL2137300 0.82 LMNA (0.40) LMNAKDM4EALDH1A1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10675359-B2 Enzymatic conjugation of antibodies INNATE PHARMA (FR) 2020-06-09 US disclosed
EP-3240573-B1 ENZYMATIC CONJUGATION OF POLYPEPTIDES INNATE PHARMA (FR) 2019-03-20 EP disclosed
US-20180193476-A1 ENZYMATIC CONJUGATION OF ANTIBODIES ARARIS BIOTECH LTD (CH) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10675359-B2 Enzymatic conjugation of antibodies DNPEP, MPO, FCGR3B LMNA 4260/4885KDM4E 3043/4885ALDH1A1 161/4885
US-20180193476-A1 ENZYMATIC CONJUGATION OF ANTIBODIES DNPEP, MPO, FCGR3B LMNA 4260/4885KDM4E 3043/4885ALDH1A1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.